Press Releases

Print

Eckert & Ziegler BEBIG celebrates 20 years of LDR Prostate Seed Brachytherapy in Spain during the XX Congreso de la SEOR

Santiago de Compostela, Spain, June 11, 2019. Taking advantage of its participation in the XX Congreso de la SEOR (Sociedad Española de Oncología Radioterápica - Spanish Society of Radiation Oncology), Eckert & Ziegler BEBIG is celebrating the 20th Anniversary of LDR Prostate Seed Brachytherapy in Spain.



20 years ago, the first prostate cancer patient was treated with LDR seeds and, since then, this treatment option experienced both broad acceptance and distribution. More than 30 centers are currently offering LDR brachytherapy, treating more than 1,000 patients annually in recent years. In the last 20 years, more than 16,000 patients have benefited from this treatment option. Spain’s strong tradition of brachytherapy can be largely attributed to the efforts of the SEOR and its brachytherapy working group. Being market leader for prostate seeds in Spain, Eckert & Ziegler BEBIG has been a long-time partner for many clinics.

On the occasion of the anniversary, the Eckert & Ziegler BEBIG team in Spain hosted a scientific event with 40 brachytherapy seed experts. The event included presentations and discussions on comparing LDR brachytherapy with other available treatment techniques.
 

Aurora Gutiérrez, Area General Manager Spain and Portugal, welcoming the guests

Furthermore, in this year´s SEOR, the ioRT-50 for superficial and intraoperative x-ray therapy was presented on the booth for the first time. The device belongs to the x-ray therapy portfolio of WOLF-Medizintechnik (WOmed) GmbH, which was acquired by Eckert & Ziegler BEBIG in December 2017. The ioRT-50 represents the company´s latest development and the first device will enter into operation this summer at Hospital Universitario de Canarias (HUC) in Santa Cruz de Tenerife.




About Eckert & Ziegler BEBIG
My partner in brachytherapy and radiation therapy
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treatment of cancer using brachytherapy. The company headquarters are in Germany, with production facilities in Germany and in the USA, as well as offices throughout Europe, Asia and the USA. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line. The company’s products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists. Eckert & Ziegler BEBIG employs approximately 145 people.

Contact:
Annica Witt
Marketing Communication Manager
marketing@dont-want-spam.bebig.com
www.bebig.com

Back